API
CDMO
About us
Services

Chongqing Sintaho - CDMO/CMO

Specialize in cGMP and Massive Production Capacity Capability: Our company is dedicated to providing comprehensive CDMO services spanning the lab scale to commercial supply. In the lab scale phase, we focus on process development, analytical method development, and molecular characterization to lay a solid foundation for R&D. Moving into the pilot scale phase, we conduct rigorous analytical method validation, process optimization, and perform small-scale production, During the clinical trial sample manufacturing phase, we offer customized samples for PhaseⅠto Ⅲ clinical trials, with options for GMP or non-GMP manufacturing. In the GMP large-scale production phase, we ensure cost-effectiveness, supply chain timeliness, and full support for regulatory submissions. In the commercial supply phase, we maintain the stability of the supply chain. Our company also excels in confidentiality...

Read full company description
Address: #600, Liuqing Rd., Maliuzui Town, Banan District, Chongqing, China, 401319, Maliuzui Town
China
China Local time:

Certified by US FDA

Well-Established Environmental, Health & Safety Protocols

Seasoned Project Execution Team

Our services:

Drug Substance

Production scale:

large

Response time:

label.follow_us Follow us:
Established in:
2016

Drug Substance (CDMO/CRO)

Small Molecule APIs
Small molecule APIs form the backbone of many pharmaceutical drugs due to their low molecular weight and ease of synthesis. They are widely used in treating a range of diseases and are typically produced through chemical synthesis in GMP-compliant facilities.
Contact supplier

Replies quickly

Contact Chongqing Sintaho Pharmaceutical Co., Ltd. for Contract Services Expertise

Connect with Chongqing Sintaho Pharmaceutical Co., Ltd., a leading pharmaceutical company from China. They offer specialized Drug Substance (CDMO/CRO). Contact Chongqing Sintaho Pharmaceutical Co., Ltd. for free and discover if they are the perfect partner for your pharmaceutical needs.

Drug Substance (CDMO/CRO)

Drug Substance CDMOs and CROs provide essential services in the development and manufacturing of active pharmaceutical ingredients (APIs). These organizations specialize in early-stage research, process development, and GMP-compliant manufacturing of drug substances for clinical and commercial use.


Pharmaoffer's Drug Substance CDMO/CRO category includes partners with expertise in small molecules, biologics, peptides, and complex chemistry, all operating under strict regulatory compliance. These providers help companies scale from lab to market efficiently and cost-effectively.


Key Functions of Drug Substance CDMOs/CROs:


  • API Research and Development: Providing early-stage discovery support, custom synthesis, and process optimization to streamline the development of drug substances.

  • Process Scale-Up and Tech Transfer: Transitioning from bench-scale to pilot and commercial scale production with validated methods and reproducibility.

  • GMP Manufacturing: Delivering high-quality API batches in GMP-certified environments, adhering to FDA, EMA, and other international standards.

  • Analytical Services: Offering comprehensive analytical method development and validation to ensure consistent quality and regulatory compliance.

  • Flexible and Specialized Capabilities: From small molecule synthesis to biologic and peptide manufacturing, these partners provide specialized services tailored to product-specific needs.


Explore Leading API CDMOs and CROs

Pharmaoffer connects you with trusted CDMOs and CROs for drug substance development. Our platform enables seamless access to specialized service providers equipped to support your API lifecycle from discovery to commercialization.

Chongqing Sintaho


Specialize in cGMP and Massive Production Capacity Capability: Our company is dedicated to providing comprehensive CDMO services spanning the lab scale to commercial supply. In the lab scale phase, we focus on process development, analytical method development, and molecular characterization to lay a solid foundation for R&D. Moving into the pilot scale phase, we conduct rigorous analytical method validation, process optimization, and perform small-scale production, During the clinical trial sample manufacturing phase, we offer customized samples for PhaseⅠto Ⅲ clinical trials, with options for GMP or non-GMP manufacturing. In the GMP large-scale production phase, we ensure cost-effectiveness, supply chain timeliness, and full support for regulatory submissions. In the commercial supply phase, we maintain the stability of the supply chain. Our company also excels in confidentiality and intellectual property protection, providing comprehensive security assurance for our clients.

Our company possesses robust production capabilities in CDMO services. With an R&D department consisting of over 70 professionals and a total headcount exceeding 3Uu. Our factory is equipped with advanced production facilities and is capable of flexibly handling the production of various compounds including cytotoxic and non-cytotoxic compounds. At the same time, it provides specialized production capabilities for high-potency drugs and XDC compounds. We are expanding the production scale to support large-scale polypeptide production and have reserved space to adapt to future growth, ensuring that we can provide efficient and reliable production solutions to meet the diverse needs of customers.